• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗肿瘤坏死因子-α疗法在银屑病和B细胞慢性淋巴细胞白血病治疗中的应用

Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia.

作者信息

Balato Anna, Lembo Serena, Cirillo Teresa, Megna Matteo, Raimondo Annunziata, Di Costanzo Luisa

机构信息

Department of Dermatology, University of Naples Federico II, Naples, Italy.

出版信息

Case Rep Dermatol. 2011 Mar 7;3(1):60-3. doi: 10.1159/000324344.

DOI:10.1159/000324344
PMID:21487463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3073755/
Abstract

Psoriasis is a chronic immunologically-based inflammatory skin disease. B-chronic lymphocytic leukemia (B-CLL) is a form of leukemia characterized by the slow and progressive accumulation of monoclonal CD5+ B lymphocytes in peripheral blood, bone marrow, lymph nodes and other organs. A T-helper 1 cytokine-mediated pathway is involved in these disorders in which tumor necrosis factor-α (TNF-α) plays a central role. TNF-α is involved in physiological phenomena, such as host defense, inflammation and cell differentiation, and in many pathological conditions, such as fever and some malignant neoplasms. TNF-α involvement in psoriasis has been well validated by the clinical success of anti-TNF-α therapy. TNF-α has been well studied in the pathogenesis of B-CLL, suggesting it as a target in B-CLL therapy. We present the case of a patient suffering from plaque psoriasis and B-CLL. Since TNF-α is reported as a common link between psoriasis and B-CLL, the patient was treated with etanercept followed by infliximab, two anti-TNF-α drugs. During 3 years of therapy, the patient did not show significant modifications of lymphocyte levels, indicating no progression of B-CLL. We report this case to highlight the possibility to administer anti-TNF-α treatment in psoriatic patients affected by concomitant B-CLL.

摘要

银屑病是一种基于免疫的慢性炎症性皮肤病。B 细胞慢性淋巴细胞白血病(B-CLL)是白血病的一种形式,其特征是外周血、骨髓、淋巴结和其他器官中出现单克隆 CD5+ B 淋巴细胞的缓慢且进行性积累。一种辅助性 T 细胞 1 细胞因子介导的途径参与了这些疾病,其中肿瘤坏死因子-α(TNF-α)起着核心作用。TNF-α 参与诸如宿主防御、炎症和细胞分化等生理现象,以及许多病理状况,如发热和一些恶性肿瘤。TNF-α 在银屑病中的作用已通过抗 TNF-α 治疗的临床成功得到充分验证。TNF-α 在 B-CLL 的发病机制中也得到了充分研究,提示它可作为 B-CLL 治疗的一个靶点。我们报告了一例患有斑块状银屑病和 B-CLL 的患者。由于 TNF-α 被报道为银屑病和 B-CLL 之间的共同联系,该患者先后接受了两种抗 TNF-α 药物依那西普和英夫利昔单抗的治疗。在 3 年的治疗期间,患者的淋巴细胞水平未出现显著变化,表明 B-CLL 无进展。我们报告此病例以强调在患有 B-CLL 的银屑病患者中给予抗 TNF-α 治疗的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/3073755/204f417a311f/cde0003-0060-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/3073755/204f417a311f/cde0003-0060-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/3073755/204f417a311f/cde0003-0060-f01.jpg

相似文献

1
Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia.抗肿瘤坏死因子-α疗法在银屑病和B细胞慢性淋巴细胞白血病治疗中的应用
Case Rep Dermatol. 2011 Mar 7;3(1):60-3. doi: 10.1159/000324344.
2
Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.B细胞慢性淋巴细胞白血病中T细胞和B细胞的细胞内肿瘤坏死因子产生
Haematologica. 2002 May;87(5):490-9.
3
TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.肿瘤坏死因子α抑制剂在银屑病和银屑病关节炎治疗中的应用
BioDrugs. 2005;19(1):47-57. doi: 10.2165/00063030-200519010-00006.
4
Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases.靶向肿瘤坏死因子α。用于调节炎症性疾病的新药。
Dermatol Clin. 2001 Oct;19(4):617-35. doi: 10.1016/s0733-8635(05)70304-1.
5
Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.白细胞介素-2增强活化的B型慢性淋巴细胞白血病(B-CLL)细胞中肿瘤坏死因子-α的产生。
Leukemia. 1993 Feb;7(2):226-34.
6
Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.慢性淋巴细胞白血病患者外周血和骨髓中T淋巴细胞和B淋巴细胞表面CD25和CD69的表达与该疾病既定预后因素之间的关系。
Adv Clin Exp Med. 2018 Jul;27(7):987-999. doi: 10.17219/acem/74437.
7
Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.高度纯化的B慢性淋巴细胞白血病细胞在无血清培养中对白介素-2以及肿瘤坏死因子α和β的增殖反应。
Leuk Res. 1989;13(11):973-80. doi: 10.1016/0145-2126(89)90004-0.
8
Involvement of Interleukin-6 in the Autocrine Stimulation of Chronic Lymphocytic Leukemia B Cells by Tumor Necrosis Factor.白细胞介素-6在肿瘤坏死因子对慢性淋巴细胞白血病B细胞的自分泌刺激中的作用。
Leuk Lymphoma. 1991;5 Suppl 1:65-9. doi: 10.3109/10428199109103381.
9
Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.超抗原导向的T细胞对慢性B淋巴细胞白血病细胞的高效杀伤作用。
Blood. 1993 Aug 15;82(4):1230-8.
10
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.抗肿瘤坏死因子-α治疗可增加慢性斑块状银屑病患者的体重:一项回顾性队列研究。
J Eur Acad Dermatol Venereol. 2008 Mar;22(3):341-4. doi: 10.1111/j.1468-3083.2007.02429.x. Epub 2007 Nov 14.

引用本文的文献

1
Role of Vitamin C on methotrexate-induced nephrotoxicity in psoriasis context: A preclinical assessment.维生素C在银屑病背景下对甲氨蝶呤诱导的肾毒性中的作用:一项临床前评估。
Toxicol Rep. 2024 Oct 21;13:101782. doi: 10.1016/j.toxrep.2024.101782. eCollection 2024 Dec.
2
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study.癌症患者银屑病的生物治疗:一项为期8年的回顾性真实世界研究。
J Clin Med. 2024 Mar 27;13(7):1940. doi: 10.3390/jcm13071940.
3
A retrospective review of the management of patients following a malignancy diagnosis on biologic therapies for the treatment of dermatological disorders.

本文引用的文献

1
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.在依那西普治疗前后,银屑病皮肤中的 TNFalpha 和其受体。
Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):961-6. doi: 10.1177/039463200902200411.
2
Psoriasis.银屑病
N Engl J Med. 2009 Jul 30;361(5):496-509. doi: 10.1056/NEJMra0804595.
3
Polymorphisms of tumor-necrosis factor-alpha - 308 and lymphotoxin-alpha + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells.
对诊断为恶性肿瘤后接受生物疗法治疗皮肤病的患者的管理进行回顾性研究。
JAAD Case Rep. 2023 Jul 17;39:81-87. doi: 10.1016/j.jdcr.2023.07.007. eCollection 2023 Sep.
4
Bilateral retinal vasculitis associated with cold agglutinin disease treated with obinutuzumab and infliximab.用奥妥珠单抗和英夫利昔单抗治疗的与冷凝集素病相关的双侧视网膜血管炎。
Am J Ophthalmol Case Rep. 2022 Nov 12;28:101752. doi: 10.1016/j.ajoc.2022.101752. eCollection 2022 Dec.
5
Erythrodermic psoriasis versus skin lesions in chronic lymphocytic leukaemia.红皮病型银屑病与慢性淋巴细胞白血病的皮肤病变
Postepy Dermatol Alergol. 2020 Apr;37(2):277-279. doi: 10.5114/ada.2020.94849. Epub 2020 May 6.
6
Soybean: a potential antipsoriasis agent.大豆:一种潜在的抗银屑病药物。
Jundishapur J Nat Pharm Prod. 2015 Feb 20;10(1):e20924. doi: 10.17795/jjnpp-20924. eCollection 2015 Feb.
7
Recalcitrant psoriasis responding to new bilogic drug: ustekinumab.对新型生物制剂优特克单抗有反应的顽固性银屑病
Ann Saudi Med. 2013 Nov-Dec;33(6):632-3. doi: 10.5144/0256-4947.2013.632.
肿瘤坏死因子-α -308和淋巴毒素-α +250的多态性:对慢性淋巴细胞白血病和非霍奇金淋巴瘤单核细胞凋亡易感性的可能调节作用
Leuk Lymphoma. 2008 Nov;49(11):2163-9. doi: 10.1080/10428190802381220.
4
Immunopathogenesis of psoriasis.银屑病的免疫发病机制。
Exp Dermatol. 2007 Oct;16(10):779-98. doi: 10.1111/j.1600-0625.2007.00629.x.
5
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha.B 细胞慢性淋巴细胞白血病细胞发挥由肿瘤坏死因子α介导的体外细胞毒性作用。
Leuk Res. 2005 Jul;29(7):829-39. doi: 10.1016/j.leukres.2005.01.004. Epub 2005 Feb 23.
6
Re-establishment of a normal apoptotic process as a therapeutic approach in B-CLL.重新建立正常的凋亡过程作为B细胞慢性淋巴细胞白血病的一种治疗方法。
Curr Drug Targets Cardiovasc Haematol Disord. 2003 Dec;3(4):261-86. doi: 10.2174/1568006033481384.
7
Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.B细胞慢性淋巴细胞白血病中T细胞产生细胞内白细胞介素-2、肿瘤坏死因子-α和干扰素-γ 。
Cytometry B Clin Cytom. 2003 Nov;56(1):23-9. doi: 10.1002/cyto.b.10052.
8
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.慢性淋巴细胞白血病患者血浆中肿瘤坏死因子-α水平的临床意义。
Blood. 2002 Aug 15;100(4):1215-9.
9
TNF-related ligands and their receptors.
Cell Signal. 1998 Sep;10(8):543-51. doi: 10.1016/s0898-6568(98)00018-7.
10
Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas.肿瘤坏死因子配体超家族:参与恶性淋巴瘤的病理学过程。
Blood. 1995 Jun 15;85(12):3378-404.